DRW Securities’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
Other funds holding JANX
DRW Securities's JANX Position: Q3 2026 in Review
DRW Securities sold out of Janux Therapeutics (JANX) in Q3 2026, closing a stake of 19,749 shares — an estimated $303K sold.
DRW Securities first reported a position in JANX in Q2 2025 and held it in 3 quarters. The position peaked at $517K in Q3 2025. 204 funds tracked by Wall St. Rank hold JANX as of Q3 2026.
- DRW Securities reported no remaining Janux Therapeutics position as of Q3 2026 after selling out during the quarter.
- DRW Securities sold 19,749 Janux Therapeutics shares in Q3 2026, an estimated $303K.
- DRW Securities first reported a position in Janux Therapeutics in Q2 2025 and held it in 3 quarters.
- DRW Securities's Janux Therapeutics position peaked at $517K in Q3 2025.
- 204 funds tracked by Wall St. Rank held Janux Therapeutics as of Q3 2026.
Based on DRW Securities's 13F filing for Q3 2026, filed 13 Nov 2026.